Sun Ups Stake In Taro

It seems that India's Sun Pharmaceutical Industries is growing impatient with opposition to its proposed acquisition of Israel's Taro Pharmaceutical Industries from some of Taro's major stakeholders, Sun has purchased the shares of a key opponent to the deal. The purchase of 3,712,557 Taro shares from Brandes Investment Partners will raise Sun's stake in Taro to 34.4%.

To read the full article, please choose one of the following options: